He explains that the new Chapter 800 will be titled "Hazardous Drugs: Handling in the Healthcare Settings" and adds that its promulgation would indicate the USP's increasingly visible role in advancing pharmacy practice.EckelFredM.Pharmacy Times...
MONITORING EXPOSURE OF NURSING AND PHARMACY PERSONNEL TO CYTOTOXIC DRUGS: URINARY MUTATION ASSAYS AND URINARY PLATINUM AS MARKERS OF ABSORPTION In a study to determine whether hospital staff who handle cytotoxic drugs show signs of drug absorption, urinary mutagenicity assays gave positive results in a...
5. Menkes DB 1997; Hazardous drugs in developing countries. The market may be healthier than the people (Editorial) British Medical Journal, 1997; 315: p.1557. 6. Syhakhang L.2002; The quality of private pharmacy services in a ... N Freemantle,J Eastaugh,M Calvert,... - 《Bmj Books...
Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence. J Occup Environ Med. 2014;56(9):901-910. Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health. 1994;...
No HD residue was detected on PPE, ancillary products, or nursing PPE in the pharmacy after using the SEVA system, providing an effective means to contain HD for drug transfer from vial to delivery system. 展开 关键词: antineoplastic drugs, surface contamination, cleaning, health care, pilot ...
23The presence of HDs and their metabolites in urine of nurses and pharmacy staff in over 100 studies demonstrates that actual exposure occurs.21Unless facilities implement, monitor, and ensure compliance with standards for HD safety, exposure remains an ongoing threat to the health of nurses and ...
Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as markers of absorption. Lancet 1984; I: 74–7 Article Google Scholar Barale R, Sozzi G, Toniolo P, et al. Sister-chromatid exchanges in lymphocytes and mutagenicity in urine...
The NU-813 Class I Containment Ventilated Enclosure (CVE)’s versatile design can be configured to compound non-sterile drugs in pharmacies or to provide personnel protection in microbiology labs. Related Resources White Paper Can a Class I and Class II BSC be in the same Sterile HD Room?
The European Statements of Hospital Pharmacy European Journal of Hospital Pharmacy, 21 Environmental contamination with cytotoxic drugs in 15 hospitals from 11 European countries—results of the MASHA project S. Buendía-Bravo,C. Gastalver-Martín,A. Iglesias-Bolaños,C. Capilla-Montes,T. Cruz-Cruz...
The use of personal protective equipment for all health care workers who may come into contact with hazardous drugs was also instituted. Waste stream ... Firouzan,Fred,Massoomi,... - 《American Journal of Health System Pharmacy Ajhp Official Journal of the American Society of Health System Phar...